AMENDED AND RESTATED SUBSCRIPTION AGREEMENTSubscription Agreement • January 10th, 2023 • Sesen Bio, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of December 29, 2022 (the “Effective Date”) by and among CARISMA Therapeutics Inc., a Delaware corporation (the “Company”), and each of the purchasers listed on Schedule I hereto, severally and not jointly (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 7 hereof.
